Newsletter Archive

1. 08.15.18 -- How To Tell If A CRA Candidate Is Lying
   8/15/2018
   08/15/18 Clinical Leader Newsletter
2. 08.13.18 -- Lilly Reduces White Space For Quicker Regulatory Approvals
   8/13/2018
   08/13/18 Clinical Leader Newsletter
3. 08.08.18 -- 10 Key Ingredients For Small Pharma GCP Quality Systems
   8/8/2018
   08/08/18 Clinical Leader Newsletter
4. 08.06.18 -- Clinical Trials: Not Broken, But In Need Of Repair
   8/6/2018
   08/06/18 Clinical Leader Newsletter
5. 08.01.18 -- Phase 1 Trial Targets The Immune System, Not The Cancer
   8/1/2018
   08/01/18 Clinical Leader Newsletter
6. 07.30.18 -- Lessons In Patient-Centricity From Rare Disease Clinical Trials
   7/30/2018
   07/30/18 Clinical Leader Newsletter
7. 07.25.18 -- 4 Keys To Making Stakeholder Partnerships Work
   7/25/2018
   07/25/18 Clinical Leader Newsletter
8. 07.23.18 -- A Cost-Utility Analysis Of Vertex’s CF Drugs — What It Teaches Us About Trial Design
   7/23/2018
   07/23/18 Clinical Leader Newsletter
9. 07.18.18 -- Will Profit Motive Be The First Big Test For RTT Legislation?
   7/18/2018
   07/18/18 Clinical Leader Newsletter
10. 07.16.18 -- QbD In Clinical Trials: A Focused Approach To Quality Assurance And Risk Management
    7/16/2018
    07/16/18 Clinical Leader Newsletter